Contemporary Management of HIV 2020

ART Management in Heavily Treatment Experienced Patients (2020)

Wednesday, December 9, 2020
Webinar -- 12:00 PM ET
https://www.clinicaloptions.com/2020ContemporaryJoin23

Agenda

Specific meetings can focus on any of the following aspects of the management of ART:

  • First-line and Switch Strategies Using Current ART Regimens
  • Emerging Approaches to Optimize ART
  • ART Strategies for Complex HIV Cases
  • Integrating New Data From CROI 2020
  • Integrating New Data From AIDS 2020
  • ART Management in Heavily Treatment Experienced Patients

The timing and agenda for each individual meeting is as follows:

  • Welcome, CME information, and baseline outcomes questions (10 mins)
  • Case 1 discussion followed by didactic slides (10-15 mins)
  • Case 2 discussion followed by didactic slides (10-15 mins)
  • Case 3 discussion followed by didactic slides (10-15 mins)
  • Question and answer session, concluding outcomes questions (15-20 mins)

Faculty

Faculty
Joseph J. Eron, MD

Professor of Medicine and Epidemiology
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Goal Statement
The goal of this activity is to improve learners’ competence in providing optimal care for HIV-infected patients through the appropriate use of contemporary ARV regimens.

Target Audience
This program is intended for physicians, registered nurses, physician assistants, pharmacists, and other healthcare professionals who provide care for patients with HIV infection.

Learning Objectives

  • Perform appropriate assessments of patients with virologic failure in the setting of extensive treatment history and complex resistance, assessing factors contributing to failure and clinical and laboratory parameters relevant to the selection of a new regimen
  • Appropriately counsel patients on potential management strategies for virologic failure in the setting of an extensive treatment history and multiclass drug resistance
  • Describe the mechanisms of action, efficacy, and safety of agents with activity against multidrug-resistant HIV in treatment-experienced patients

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Individual topic ACPE UANs available within the Event Date tab.

Type of Activity: Application

Disclosure of Conflicts of Interest 
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any relevant conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.